Abstract

Psoriasis in adults is associated with an increased risk of metabolic disease. Various cardiometabolic comorbidities have been reported in childhood psoriasis, but only a few studies have analyzed the prevalence of metabolic syndrome. We performed a single-center prospective study investigating the prevalence of metabolic syndrome and insulin resistance in children with psoriasis. The prevalence of metabolic syndrome was evaluated in 60 pre-pubertal children with psoriasis (age: 3–10 years), accordingly to recently established criteria for the diagnosis of metabolic syndrome in children. Insulin resistance was considered altered when the homeostatic model assessment (HOMA-IR) for insulin resistance was ≥ 90th sex- and age-specific percentile and HOMA 2-IR was > 1.8. Eighteen (30%) children with psoriasis were found to have metabolic syndrome. Sixteen (27%) children were found to have insulin resistance.Conclusion: Our data underline the importance of assessing metabolic syndrome not only in adults and adolescents but also in young children with psoriasis.What is Known:• Psoriasis in adults is strongly associated with metabolic disease and insulin resistance.• Very limited data are available on the prevalence of metabolic syndrome and insulin resistance in pre-pubertal children with psoriasis.What is New:• This study reports that in pre-pubertal children with psoriasis, there is a high prevalence of metabolic syndrome and insulin resistance.• In children with psoriasis metabolic syndrome risk factors should be assessed.

Highlights

  • This study reports that in pre-pubertal children with psoriasis, there is a high prevalence of metabolic syndrome and insulin resistance

  • Few data are available about this topic in children with psoriasis as most of the available studies analyze the prevalence of only single components of metabolic syndrome (MetS) [5,6,7,8,9] and not the overall prevalence of MetS [9]

  • The following data were collected for each patient by the same team of dermatologists experienced in pediatric dermatology: age, sex, height, body weight, body mass index (BMI), systolic and diastolic blood pressure (BP), waist circumference (WC), waist-to-height ratio (WHtR), and family history of psoriasis and metabolic or cardiovascular diseases

Read more

Summary

Introduction

Psoriasis in adults is associated with an increased risk of metabolic syndrome (MetS) [1,2,3,4].Few data are available about this topic in children with psoriasis as most of the available studies analyze the prevalence of only single components of MetS [5,6,7,8,9] and not the overall prevalence of MetS [9].The few studies on MetS in childhood psoriasis evaluated only a small number of children and a still more limited number of young children [10,11,12].We performed a single-center study, investigating the prevalence of MetS and levels of insulin resistance in a population of pre-pubertal children with psoriasis and the correlations with clinical and anamnestic data. Psoriasis in adults is associated with an increased risk of metabolic syndrome (MetS) [1,2,3,4]. Few data are available about this topic in children with psoriasis as most of the available studies analyze the prevalence of only single components of MetS [5,6,7,8,9] and not the overall prevalence of MetS [9]. The few studies on MetS in childhood psoriasis evaluated only a small number of children and a still more limited number of young children [10,11,12]. We performed a single-center study, investigating the prevalence of MetS and levels of insulin resistance in a population of pre-pubertal children with psoriasis and the correlations with clinical and anamnestic data

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call